Guam vs Malta: The number of people with susceptibility test result for rifampicin
Guam
92.11
in 2021
Malta
93.1
in 2021
Guam rank
62nd
Malta rank
59th
The number of people with susceptibility test result for rifampicin over time
- Guam
- Malta
How they compare
Malta currently reports 93.1 against 92.11 in Guam, a difference of 0.99.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Guam ahead.
Guam ranks 62nd and Malta ranks 59th of 146 countries.
Guam has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guam | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 98.77 | 91.41 | 7.37 | Guam |
| 2020s | 94.77 | 90.14 | 4.63 | Guam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Guam or Malta?
- Malta, at 93.1 against 92.11 in Guam as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Guam and Malta?
- 0.99, with Malta ahead.
- How many years of comparable data are there for Guam and Malta?
- 5 years are reported by both, from 2017 to 2021.
- How do Guam and Malta rank globally for the number of people with susceptibility test result for rifampicin?
- Guam ranks 62nd and Malta ranks 59th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.